Lantheus Holdings Inc (LNTH) FinancialsLNTHFinancialLantheus Holdings Inc

Lantheus Holdings, Inc. (LNTH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is DEFINITY, accounting for 64.5% of total sales, equivalent to $60.73M. Other significant revenue streams include TechneLite and Other nuclear. Understanding this composition is critical for investors evaluating how LNTH navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Lantheus Holdings, Inc. maintains a gross margin of 63.64%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.56%, while the net margin is 19.33%. These profitability ratios, combined with a Return on Equity (ROE) of 22.21%, provide a clear picture of how effectively LNTH converts its operational activities into shareholder value.

In the context of the broader market, LNTH competes directly with industry leaders such as BLCO and TFX. With a market capitalization of $6.59B, it holds a leading position in the sector. When comparing efficiency, LNTH's gross margin of 63.64% stands against BLCO's 58.11% and TFX's 58.16%. Such benchmarking helps identify whether Lantheus Holdings, Inc. is trading at a premium or discount relative to its financial performance.

The company reported a net income of $75,029,000 in Q2 2026, with a gross margin of 63.64%. The forward P/E ratio is 17.79, indicating moderate valuation relative to earnings expectations.